Looking at this again - Investor Presentation.
And then using the CEO's estimates from yesterday's The Australian article.
Mr Read said MedAdvisor expected to be in more than 50 per cent of pharmacies in Australia by mid-December and was looking at opportunities to expand internationally. “I think we can get to between two and three million people on the app this year, possibly more,” he said.
This new updated estimate is two to three times beyond previous estimates and a year earlier.
Only Management know the current stats and it would be a brave or foolish statement to make if the target numbers didn't eventuate.
Milestone shares will be awarded to MMG based on the GP Link pilot and HMR (Home Medicine Reviews), all of which are revenue streams for MDR.
Exciting 6 months coming up.
- Forums
- ASX - By Stock
- Ann: Major Biopharmaceutical Signs to Patient Engagement Program-MDR.AX
Looking at this again - Investor Presentation. [ATTACH] And then...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
(20min delay)
|
|||||
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $215.0M |
Open | High | Low | Value | Volume |
29.0¢ | 30.0¢ | 27.5¢ | $254.8K | 889.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 39326 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.5¢ | 2917 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15939 | 0.335 |
3 | 26030 | 0.330 |
1 | 100000 | 0.325 |
4 | 89161 | 0.320 |
2 | 29526 | 0.315 |
Price($) | Vol. | No. |
---|---|---|
0.360 | 24455 | 1 |
0.380 | 50000 | 1 |
0.385 | 100000 | 1 |
0.390 | 54500 | 1 |
0.395 | 10000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
MDR (ASX) Chart |